ACIR
@acir_org
Accelerating Cancer Immunotherapy Research. A free weekly digest of the latest findings in the field. We also make cool cartoons :) Listen to @ImmunoTalks.
ID: 875012589985640450
http://ACIR.org 14-06-2017 15:30:33
3,3K Tweet
2,2K Followers
1,1K Following
To support anti-BCMA CAR T cell persistence, Rakhshandehroo et al. generated an antigen- targeted “CAR enhancer” (CAR-E) by fusing BCMA to a low-affinity IL-2 molecule. bit.ly/3XmUThv Dana-Farber Mohammad Rashidian
